In the present study, with the aim of searching for alternative antifungal agents, a KT produced by the newly isolated W. anomalus 1F1 strain  was assayed in vitro against clinical isolates and laboratory strains of C. albicans and C. glabrata displaying known mutations and different susceptibility to fluconazole .